This inventor holds 5 USPTO granted patents and 8 published patent applications. Top assignee: Nec Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Ziqi Chen - Innovator in Binding Peptide Generation
Introduction
Ziqi Chen is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of biotechnology, particularly in the area of peptide generation for MHC class I proteins. His innovative approach utilizes deep reinforcement learning to enhance the understanding and application of binding peptides.
Latest Patents
Ziqi Chen holds a patent titled "Binding peptide generation for MHC class I proteins with deep reinforcement learning." This patent presents a method for generating binding peptides that can be presented by any given Major Histocompatibility Complex (MHC) protein. The method involves enabling a Reinforcement Learning (RL) agent to interact with a peptide mutation environment. By mutating the peptide and observing the resulting scores, the RL agent learns to form a mutation policy. This policy allows for the iterative mutation of amino acids in the peptide to achieve desired presentation scores, ultimately generating qualified peptides and binding motifs for MHC Class I proteins. He has 1 patent to his name.
Career Highlights
Ziqi Chen is currently employed at NEC Corporation, where he continues to push the boundaries of innovation in his field. His work is characterized by a strong focus on the intersection of artificial intelligence and biotechnology, which has the potential to revolutionize how binding peptides are generated and utilized.
Collaborations
Ziqi collaborates with Renqiang Min, who is also a key contributor in their research endeavors. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
Ziqi Chen's work in binding peptide generation represents a significant advancement in biotechnology. His innovative methods and dedication to research continue to pave the way for future discoveries in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
